1-4 of 4
Michael Roderick Cook
Close
Sort by
Journal Articles

Real-World Evidence in the United States (US) of the Impact of Bridging Therapy Prior to Axicabtagene Ciloleucel (Axi-Cel) for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL)

Michael Roderick Cook, Roni Shouval, Miguel-Angel Perales, Evandro Bezerra, Alex Niu, Saurabh Dahiya, Loretta J. Nastoupil, Caron A. Jacobson, L. Elizabeth Budde, Amanda L. Olson, Brent R. Logan, Zhen-Huan Hu, Hai-Lin Wang, Zhong-Cheng Luo, Jenny J. Kim, Harry W. Smith, Andrew Lee, Fang Sun, Marcelo Pasquini, Frederick L. Locke
Journal: Blood
Blood (2023) 142 (Supplement 1): 103.
https://doi.org/10.1182/blood-2023-175034
Published: 2023
Journal Articles

Improved Survival Outcomes for Intensive Versus Standard Chemoimmunotherapy in Primary Mediastinal B-Cell Lymphoma: A Meta-Analysis of 4068 Patients

Michael Roderick Cook, Lacey S. Williams, Scott C Dorris, Paul Kolm, Kieron Dunleavy
Journal: Blood
Blood (2022) 140 (Supplement 1): 9567–9568.
https://doi.org/10.1182/blood-2022-162852
Published: 2022
Journal Articles

P53 Overexpression Predicts Poor Outcome in High-Grade B-Cell Lymphoma - a Comparative Analysis of Aggressive B-Cell Lymphomas

Michael Roderick Cook, Sumeyye Culfaci, Mihriye Mete, Metin Ozdemirli, Kieron Dunleavy
Journal: Blood
Blood (2022) 140 (Supplement 1): 12096–12097.
https://doi.org/10.1182/blood-2022-162785
Published: 2022
Journal Articles

Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19

Michael Roderick Cook, MD, Kaitlyn C Dykes, MDBS, Katherine White, Jaeil Ahn, PhD, Nathan Cobb, MD, Catherine Lai, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-138941
Published: 2020